Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MLSS Stock Forecast 2025-2026
$0.93
Current Price
$69.77M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MLSS Price Targets
+222.6%
To High Target of $3.00
+128.5%
To Median Target of $2.13
+34.4%
To Low Target of $1.25
MLSS Price Momentum
-2.1%
1 Week Change
+2.2%
1 Month Change
+36.8%
1 Year Change
-3.1%
Year-to-Date Change
-33.1%
From 52W High of $1.39
+60.3%
From 52W Low of $0.58
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Milestone (MLSS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MLSS and similar high-potential opportunities.
Latest MLSS Stock Price Targets & Analyst Predictions
Based on our analysis of 1 Wall Street analyst, MLSS has a bullish consensus with a median price target of $2.13 (ranging from $1.25 to $3.00). Currently trading at $0.93, the median forecast implies a 128.5% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Bruce Jackson at Benchmark, suggesting a 34.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLSS Analyst Ratings
2
Buy
0
Hold
0
Sell
MLSS Price Target Range
Low
$1.25
Average
$2.13
High
$3.00
Current: $0.93
Latest MLSS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLSS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 20, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $1.25 |
| Oct 10, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Initiates | $1.25 |
Milestone Scientific Inc. (MLSS) Competitors
The following stocks are similar to Milestone based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MLSS
Milestone Scientific
mkt cap
74.46M
Milestone Scientific Inc. (MLSS) Financial Data
Milestone Scientific Inc. has a market capitalization of $69.77M with a P/E ratio of 0.0x. The company generates $8.63M in trailing twelve-month revenue with a -54.6% profit margin.
Revenue growth is -10.9% quarter-over-quarter, while maintaining an operating margin of -101.4% and return on equity of -68.1%.
Valuation Metrics
Market Cap
$69.77M
Enterprise Value
$68.42M
P/E Ratio
0.0x
PEG Ratio
-22.3x
Price/Sales
8.1x
Growth & Margins
Revenue Growth (YoY)
-10.9%
Gross Margin
+75.0%
Operating Margin
-101.4%
Net Margin
-54.6%
EPS Growth
-10.9%
Financial Health
Cash/Price Ratio
+4.5%
Current Ratio
2.5x
Debt/Equity
6.0x
ROE
-68.1%
ROA
-39.9%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Milestone Scientific Inc. (MLSS) Business Model
About Milestone Scientific Inc.
What They Do
Develops advanced medical devices for drug delivery.
Business Model
The company generates revenue by developing, producing, and commercializing innovative medical devices that utilize patented pressure feedback technology for controlled drug delivery. Its primary product, the STA System, is focused on dental anesthesia, but there are plans to expand into other medical markets such as epidural anesthetics.
Additional Information
Milestone Scientific aims to enhance patient comfort and safety while improving procedural efficacy in various medical applications. The company positions itself as a key player in the medical device industry, reflecting a broader trend towards technology-driven, minimally invasive medical practices.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
17
CEO
Mr. Neal Ira Goldman CFA
Country
United States
IPO Year
1995
Website
www.milestonescientific.comMilestone Scientific Inc. (MLSS) Latest News & Analysis
Latest News
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
1 month ago
Quick Summary
Dr. Roman Kosiborod will use CompuFlo® technology to improve precision in pain management procedures, potentially enhancing treatment outcomes.
Why It Matters
The use of CompuFlo® by Dr. Kosiborod indicates potential advancements in pain management, which could drive demand for the technology and benefit related medical device companies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Dr. Ilana Etelzon has integrated the CompuFlo® Epidural System into her practice after a positive clinical experience, indicating potential growth for the product's adoption in medical settings.
Why It Matters
The integration of the CompuFlo® Epidural System by Dr. Etelzon indicates growing acceptance and potential market expansion, positively impacting the company's stock and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CompuFlo® Epidural System is seeing increased adoption, following the recent Medicare price assignment announcement.
Why It Matters
Growing adoption of the CompuFlo® Epidural System suggests increased revenue potential and market share for the company, signaling strong demand and positive market positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (NYSE: MLSS) will present at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference on December 11, 2024, in New York City.
Why It Matters
Milestone Scientific’s participation in a prominent investor conference highlights its growth potential and leadership visibility, which may attract investor interest and affect stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
5 months ago
Quick Summary
A new contract has been awarded that presents substantial market opportunities within federal healthcare systems.
Why It Matters
The contract indicates potential revenue growth and expansion for companies involved in federal healthcare, suggesting increased demand and profitability in the sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (NYSE: MLSS) held its Q3 2024 earnings call on November 15, 2024, featuring CEO Arjan Haverhals and VP of Finance Keisha Harcum.
Why It Matters
Milestone Scientific's Q3 earnings call provides insights into financial performance and strategic direction, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About MLSS Stock
What is Milestone Scientific Inc.'s (MLSS) stock forecast for 2025?
Based on our analysis of 1 Wall Street analysts, Milestone Scientific Inc. (MLSS) has a median price target of $2.13. The highest price target is $3.00 and the lowest is $1.25.
Is MLSS stock a good investment in 2025?
According to current analyst ratings, MLSS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.93. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MLSS stock?
Wall Street analysts predict MLSS stock could reach $2.13 in the next 12 months. This represents a 128.5% increase from the current price of $0.93. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Milestone Scientific Inc.'s business model?
The company generates revenue by developing, producing, and commercializing innovative medical devices that utilize patented pressure feedback technology for controlled drug delivery. Its primary product, the STA System, is focused on dental anesthesia, but there are plans to expand into other medical markets such as epidural anesthetics.
What is the highest forecasted price for MLSS Milestone Scientific Inc.?
The highest price target for MLSS is $3.00 from at , which represents a 222.6% increase from the current price of $0.93.
What is the lowest forecasted price for MLSS Milestone Scientific Inc.?
The lowest price target for MLSS is $1.25 from Bruce Jackson at Benchmark, which represents a 34.4% increase from the current price of $0.93.
What is the overall MLSS consensus from analysts for Milestone Scientific Inc.?
The overall analyst consensus for MLSS is bullish. Out of 1 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.13.
How accurate are MLSS stock price projections?
Stock price projections, including those for Milestone Scientific Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 4:08 AM UTC